A digital view of the world illustrates how Astellas is a global company committed to serving patients worldwide.

News

Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.

CHMP Issues Positive Opinion to Include New Data in European Label for XTANDI® (enzalutamide)
Apr 7, 2016
-- TERRAIN Trial Showed Statistically Significant PFS Improvement with Enzalutamide Versus Bicalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer --